Listen: HHS Files Challenge Over Rights To Gilead’s HIV-Prevention Drug

The drug Truvada, used to halt HIV infection, has been shown to be over 90 percent effective when used correctly. (Heidi de Marco/KHN)

Kaiser Health News’ Shefali Luthra spoke with Jeremy Hobsons, host of WBUR’s Hear & Now, about the Trump administration’s lawsuit over sales of the HIV-prevention drug Truvada.

You can read the text of the lawsuit here.

Check out this earlier, related California Healthline story: Out-Of-Pocket Costs Put HIV Prevention Drug Out Of Reach For Many At Risk (Luthra and Gorman, 7/16/2018).

Related Topics

Courts Health Industry Pharmaceuticals Public Health